{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Moroccan phyto-chemicals", "PPAR\u03b3", "energy free binding calculation", "molecular dynamic simulation", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37901293", "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "31"}], "Language": ["eng"], "ELocationID": ["10.6026/97320630019795"], "Journal": {"ISSN": "0973-2063", "JournalIssue": {"Volume": "19", "Issue": "7", "PubDate": {"Year": "2023"}}, "Title": "Bioinformation", "ISOAbbreviation": "Bioinformation"}, "ArticleTitle": "Molecular docking analysis of PPAR\u03b3 with phytochemicals from Moroccan medicinal plants.", "Pagination": {"StartPage": "795", "EndPage": "806", "MedlinePgn": "795-806"}, "Abstract": {"AbstractText": ["PPAR\u03b3 agonists play a crucial role in regulating metabolic homeostasis for treating type-2 diabetes (T2D). Due to the adverse side effects associated with thiazolidinediones, a class of PPAR\u03b3 agonists, there is a growing interest in identifying natural compounds from medicinal plants that have the potential to bind PPAR\u03b3. In this study, we extensively investigated Moroccan phytochemicals using computational structure-based screening with the crystal structure of the PPAR\u03b3 ligand-binding domain (PDB ID: 7awc) to discover novel phytochemicals targeting PPAR\u03b3. The docking results of 540 Moroccan phytochemicals were integrated into online databases for further exploitation through in-depth studies. Drug-likeness analysis was performed to assess the phytochemicals drug-like properties. Two promising phytochemicals, 3,4-dicaffeoylquinic acid and Chlorogenic acid, were identified, both exhibiting high docking affinity and unique binding site interactions compared to the established PPAR\u03b3 full agonist, rosiglitazone. Molecular dynamics simulations of 100 ns were conducted to examine the stability of the complexes formed by both compounds within the PPAR\u03b3 active site, and their dynamic behavior was compared to the reference structure of PPAR\u03b3 alone and with rosiglitazone. Binding free energy calculations demonstrated that 3,4-dicaffeoylquinic acid and Chlorogenic acid exhibited higher binding free energy than the reference agonist, suggesting their potential as candidates for experimental validation in future drug discovery efforts targeting PPAR\u03b3 for the treatment of T2D and metabolic syndrome."], "CopyrightInformation": "\u00a9 2023 Biomedical Informatics."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco."}, {"Identifier": [], "Affiliation": "Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca."}], "LastName": "Elkhattabi", "ForeName": "Lamiae", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco."}], "LastName": "Zouhdi", "ForeName": "Salwa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco."}], "LastName": "Moussetad", "ForeName": "Fairouz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco."}], "LastName": "Kettani", "ForeName": "Anass", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca."}], "LastName": "Barakat", "ForeName": "Abdelhamid", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Morocco."}], "LastName": "Saile", "ForeName": "Rachid", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Bioinformation", "NlmUniqueID": "101258255", "ISSNLinking": "0973-2063"}, "CoiStatement": "Authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alberti K, et al. Diabet Med . 1998;15:539.", "ArticleIdList": ["9686693"]}, {"Citation": " \n https://pubmed.ncbi.nlm.nih.gov/11368702/\n"}, {"Citation": "Einhorn D, et al. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol . 2003;9:237.", "ArticleIdList": ["0"]}, {"Citation": "Alberti K, et al. Lancet Lond Engl . 2005;366:1059.", "ArticleIdList": ["16182882"]}, {"Citation": "Wilson P, et al. Circulation . 2005;112:3066.", "ArticleIdList": ["16275870"]}, {"Citation": "Alberti K, et al. Circulation . 2009;120:1640.", "ArticleIdList": ["19805654"]}, {"Citation": "Serafino-Agrusa L, et al. World J Clin Cases WJCC . 2015;3:285.", "ArticleIdList": ["PMC4360500", "25789301"]}, {"Citation": "Caterson I, et al. Circulation . 2004;110:e476..", "ArticleIdList": ["15520332"]}, {"Citation": "Rochlani Y, et al. Ther Adv Cardiovasc Dis . 2017;11:215.", "ArticleIdList": ["PMC5933580", "28639538"]}, {"Citation": "Berger JP, et al. Trends Pharmacol Sci . 2005;26:244.", "ArticleIdList": ["15860371"]}, {"Citation": "Monsalve FA, et al. Mediators Inflamm . 2013;2013:549627.", "ArticleIdList": ["PMC3678499", "23781121"]}, {"Citation": "Stump M, et al. Curr Hypertens Rep . 2015;17:89.", "ArticleIdList": ["PMC6766749", "26462805"]}, {"Citation": "Mansour M. Prog. Mol. Biol. Transl. Sci. . 2014;121:217.", "ArticleIdList": ["24373239"]}, {"Citation": "Algandaby MM. Saudi J Biol Sci . 2020;27:1310.", "ArticleIdList": ["PMC7182989", "32346340"]}, {"Citation": "Fitzgerald ML, et al. J Mol Med Berl Ger . 2002;80:271.", "ArticleIdList": ["12021839"]}, {"Citation": "Lalloyer F, Staels B. Arterioscler Thromb Vasc Biol . 2010;30:894.", "ArticleIdList": ["PMC2997800", "20393155"]}, {"Citation": " \n https://www.ncbi.nlm.nih.gov/books/NBK67752/\n"}, {"Citation": "Martens FMAC, et al. Drugs . 2002;62:1463.", "ArticleIdList": ["12093315"]}, {"Citation": "Koshiyama H, et al. Lipoprotein Metabolism and Atherogenesis. Tokyo, Japan: Springer Japan; 2000. 154 pp.", "ArticleIdList": ["10.1007/978-4-431-68424-4_34"]}, {"Citation": "Werner AL, Travaglini MT. Pharmacotherapy . 2001;21:1082.", "ArticleIdList": ["11560198"]}, {"Citation": "Phillips LS, et al. Diabetes Care . 2001;24:308.", "ArticleIdList": ["11213884"]}, {"Citation": "Kaul S, Diamond GA. Curr Atheroscler Rep . 2008;10:398.", "ArticleIdList": ["18706281"]}, {"Citation": "Trott O, Olson AJ. J Comput Chem . 2010;31:455.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": " \n https://discover.3ds.com/discovery-studio-visualizer-download\n."}, {"Citation": "Lagorce D, et al. Bioinforma Oxf Engl. . 2017;33:3658.", "ArticleIdList": ["28961788"]}, {"Citation": "Pronk S, et al. Bioinformatics . 2013;29:845.", "ArticleIdList": ["PMC3605599", "23407358"]}, {"Citation": "Sch\u00fcttelkopf AW, van Aalten DMF. Acta Crystallogr D Biol Crystallogr . 2004;60:1355.", "ArticleIdList": ["15272157"]}, {"Citation": " \n https://plasma-gate.weizmann.ac.il/Grace/\n"}, {"Citation": "Genheden S, Ryde U. Expert Opin Drug Discov. . 2015;10:449.", "ArticleIdList": ["PMC4487606", "25835573"]}, {"Citation": "Brust R, et al. Nat Commun . 2018;9:4687.", "ArticleIdList": ["PMC6224492", "30409975"]}, {"Citation": "Berger J, Moller DE. Annu Rev Med . 2002;53:409.", "ArticleIdList": ["11818483"]}, {"Citation": "Nissen SE, Wolski K. N Engl J Med. . 2007;356:2457.", "ArticleIdList": ["17517853"]}, {"Citation": "Wang L, et al. Front Nutr. . 2022;9:439119.", "ArticleIdList": ["0"]}, {"Citation": "Yan Y, et al. J Immunol Res. . 2020;2020:9680508.", "ArticleIdList": ["PMC7275206", "32566690"]}, {"Citation": "Li SY, et al. Biomed Environ Sci BES. . 2009;22:122.", "ArticleIdList": ["19618689"]}, {"Citation": "Lou Z, et al. J Food Sci. . 2011;76:M398..", "ArticleIdList": ["22417510"]}, {"Citation": "Wu L. J Zhejiang Univ Sci B. . 2007;8:673.", "ArticleIdList": ["PMC1963434", "17726749"]}, {"Citation": "Meng S, et al. Evid-Based Complement Altern Med ECAM. . 2013;2013:801457.", "ArticleIdList": ["PMC3766985", "24062792"]}, {"Citation": "Berrani A, et al. J Basic Clin Physiol Pharmacol. . 2018;30:251.", "ArticleIdList": ["30864419"]}, {"Citation": "Msaada K, et al. Arab J Chem. 2017;10:S3176. doi: 10.1016/j.arabjc.2013.12.011.", "ArticleIdList": ["10.1016/j.arabjc.2013.12.011"]}, {"Citation": "Peng SG, et al. BioMed Res Int. . 2018;2018:8594767.", "ArticleIdList": ["PMC6304673", "30627576"]}, {"Citation": "Sanchez MB, et al. Biomed Pharmacother Biomedecine Pharmacother. . 2017;94:169.", "ArticleIdList": ["28759754"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "1"}, {"Year": "2023", "Month": "7", "Day": "31"}, {"Year": "2023", "Month": "7", "Day": "31"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "6", "Minute": "47"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "4", "Minute": "49"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["37901293", "PMC10605085", "10.6026/97320630019795", "97320630019795"]}}], "PubmedBookArticle": []}